(Ozempic, approved for Type 2 diabetes, and Wegovy, approved for weight loss, both contain the same drug, called semaglutide.) Tchang said that while earlier clinical trials for drugs like semaglutide for diabetes and weight loss found that the drugs also improved blood pressure and cholesterol two risk factors for heart disease the Food and Drug Administration needs standalone studies looking at heart health in order for a company to be able to say the drug has that benefit
A hepatic impairment study covering Child-Pugh A, B, and C categories similarly showed no clinically significant changes in semaglutide pharmacokinetics 13
An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia
Sustainable weight loss requires mental and emotional support
PLoS One 14:e214250
Contribution to selenium speciation in cerebrospinal fluid samples